Experiences and Perspectives of Polycystic Kidney Disease Patients following a Diet of Reduced Osmoles, Protein, and Acid Precursors Supplemented with Water: A Qualitative Study

Jacob M Taylor, Lauren Ptomey, Jill M Hamilton-Reeves, Debra K Sullivan, Catherine Creed, Susan E Carlson, Donald E Wesson, Jared J Grantham, Cheryl A Gibson, Jacob M Taylor, Lauren Ptomey, Jill M Hamilton-Reeves, Debra K Sullivan, Catherine Creed, Susan E Carlson, Donald E Wesson, Jared J Grantham, Cheryl A Gibson

Abstract

Background: Salt, protein, acid precursors, and fluid intake have been identified as factors that influence cyst growth in ADPKD. Unfortunately, the feasibility of following these dietary restrictions/enhancements from a patient's point-of-view has yet to be studied. The purpose of this study is to understand better the experiences of patients following a relatively complex dietary prescription targeting these factors.

Methods: Twelve adults with ADPKD and kidney function >30ml/min/1.73m2 were recruited from the University of Kansas Medical Center Polycystic Kidney Disease clinic. In a qualitative design, semi-structured interviews of participants were conducted following a four week dietary intervention (experimental diet lower in sodium, protein, and acid precursors, and supplemented with water) either face-to-face or by telephone. All interviews were recorded, transcribed verbatim, and checked for accuracy. Transcripts were analyzed thematically for emerging themes.

Results: Participants reported that eating less meat and more fruits and vegetables were the easiest components of the diet, whereas reaching the daily goal amount of fruits and vegetables and tracking the diet constantly were the most difficult components. Participants had little difficulty with fluid intake and reported the prescribed fluid goal as achievable. The tracking system for fruits and vegetables and protein was reported to be both helpful and intuitive, but tracking their intake on paper was tedious. Eating out was the most significant barrier to following the diet with some individuals avoiding restaurants in order to comply with the dietary prescription.

Conclusion: Participants on the experimental diet heightened their awareness of the consumption of dietary salt, protein, acid precursors, and fluid intake. Additionally, most participants believed adherence to the prescribed diet was feasible. However, participants wanted less cumbersome ways to track and monitor the diet, especially given that the prescribed diet is designed for lifelong adherence. Future studies should focus on targeting these specific dietary factors in larger groups of more ethnically and culturally diverse populations to help inform clinicians and how best to help diverse populations adhere to the dietary intervention.

Trial registration: ClinicalTrials.gov NCT01810614.

Conflict of interest statement

Competing Interests: This study was partially funded by Abbott Nutrition. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.

References

    1. Grantham JJ. Clinical practice. Autosomal dominant polycystic kidney disease. The New England journal of medicine. 2008;359(14):1477–85. 10.1056/NEJMcp0804458 .
    1. Cowley BD Jr., Grantham JJ, Muessel MJ, Kraybill AL, Gattone VH 2nd. Modification of disease progression in rats with inherited polycystic kidney disease. American journal of kidney diseases: the official journal of the National Kidney Foundation. 1996;27(6):865–79. .
    1. Torres VE, Grantham JJ, Chapman AB, Mrug M, Bae KT, King BF Jr., et al. Potentially modifiable factors affecting the progression of autosomal dominant polycystic kidney disease. Clinical journal of the American Society of Nephrology: CJASN. 2011;6(3):640–7. 10.2215/CJN.03250410
    1. Banerjee T, Crews DC, Wesson DE, Tilea A, Saran R, Rios Burrows N, et al. Dietary acid load and chronic kidney disease among adults in the United States. BMC nephrology. 2014;15:137 10.1186/1471-2369-15-137
    1. Tanner GA, Tanner JA. Citrate therapy for polycystic kidney disease in rats. Kidney international. 2000;58(5):1859–69. 10.1111/j.1523-1755.2000.00357.x .
    1. Goraya N, Simoni J, Jo C, Wesson DE. Dietary acid reduction with fruits and vegetables or bicarbonate attenuates kidney injury in patients with a moderately reduced glomerular filtration rate due to hypertensive nephropathy. Kidney international. 2012;81(1):86–93. 10.1038/ki.2011.313 .
    1. Goraya N, Wesson DE. Acid-base status and progression of chronic kidney disease. Current opinion in nephrology and hypertension. 2012;21(5):552–6. .
    1. Goraya N, Wesson DE. Is dietary Acid a modifiable risk factor for nephropathy progression? American journal of nephrology. 2014;39(2):142–4. 10.1159/000358602 .
    1. Wesson DE, Simoni J. Acid retention during kidney failure induces endothelin and aldosterone production which lead to progressive GFR decline, a situation ameliorated by alkali diet. Kidney international. 2010;78(11):1128–35. 10.1038/ki.2010.348 .
    1. Phisitkul S, Khanna A, Simoni J, Broglio K, Sheather S, Rajab MH, et al. Amelioration of metabolic acidosis in patients with low GFR reduced kidney endothelin production and kidney injury, and better preserved GFR. Kidney international. 2010;77(7):617–23. 10.1038/ki.2009.519 .
    1. Banerjee T, Crews DC, Wesson DE, Tilea AM, Saran R, Rios-Burrows N, et al. High Dietary Acid Load Predicts ESRD among Adults with CKD. Journal of the American Society of Nephrology: JASN. 2015. 10.1681/ASN.2014040332 .
    1. Nagao S, Nishii K, Katsuyama M, Kurahashi H, Marunouchi T, Takahashi H, et al. Increased water intake decreases progression of polycystic kidney disease in the PCK rat. Journal of the American Society of Nephrology: JASN. 2006;17(8):2220–7. 10.1681/ASN.2006030251 .
    1. Ortner Hadziabdic M, Mucalo I, Hrabac P, Matic T, Rahelic D, Bozikov V. Factors predictive of drop-out and weight loss success in weight management of obese patients. Journal of human nutrition and dietetics: the official journal of the British Dietetic Association. 2015;28 Suppl 2:24–32. 10.1111/jhn.12270 .
    1. McCauley LR, Dyer AJ, Stern K, Hicks T, Nguyen MM. Factors influencing fluid intake behavior among kidney stone formers. The Journal of urology. 2012;187(4):1282–6. 10.1016/j.juro.2011.11.111 .
    1. Cianciaruso B, Pota A, Pisani A, Torraca S, Annecchini R, Lombardi P, et al. Metabolic effects of two low protein diets in chronic kidney disease stage 4-5—a randomized controlled trial. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association—European Renal Association. 2008;23(2):636–44. 10.1093/ndt/gfm576 .
    1. McMahon EJ, Campbell KL, Mudge DW, Bauer JD. Achieving salt restriction in chronic kidney disease. International journal of nephrology. 2012;2012:720429 10.1155/2012/720429
    1. Taylor JM, Hamilton-Reeves JM, Sullivan DK, Gibson CA, Creed C, Carlson SE, et al. Diet and polycystic kidney disease: A pilot intervention study. Clin Nutr. 2016. 10.1016/j.clnu.2016.01.003 .
    1. Wang CJ, Creed C, Winklhofer FT, Grantham JJ. Water prescription in autosomal dominant polycystic kidney disease: a pilot study. Clinical journal of the American Society of Nephrology: CJASN. 2011;6(1):192–7. 10.2215/CJN.03950510
    1. Frassetto LA, Lanham-New SA, Macdonald HM, Remer T, Sebastian A, Tucker KL, et al. Standardizing terminology for estimating the diet-dependent net acid load to the metabolic system. The Journal of nutrition. 2007;137(6):1491–2. .
    1. SF S. Maintaining a nutrient database in a changing marketplace: Keeping pace with changing food products- A research perspective. J Food Comp and Anal. 2001;14:315–22.
    1. Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77–101.
    1. Ritchie J, Lewis J, Lewis PSPJ, Nicholls CMN, Ormston R. Qualitative Research Practice: A Guide for Social Science Students and Researchers: SAGE Publications; 2013.
    1. Miles MB, Huberman AM, Saldana J. Qualitative Data Analysis: A Methods Sourcebook: SAGE Publications; 2013.
    1. Shenton AK. Strategies for ensuring trustworthiness in qualitative research projects. Education for Information. 2004;22(2):63–75.
    1. He FJ, MacGregor GA. A comprehensive review on salt and health and current experience of worldwide salt reduction programmes. Journal of human hypertension. 2009;23(6):363–84. 10.1038/jhh.2008.144 .
    1. Ecder T, Edelstein CL, Fick-Brosnahan GM, Johnson AM, Duley IT, Gabow PA, et al. Progress in blood pressure control in autosomal dominant polycystic kidney disease. American journal of kidney diseases: the official journal of the National Kidney Foundation. 2000;36(2):266–71. 10.1053/ajkd.2000.8970 .
    1. Schrier RW, Abebe KZ, Perrone RD, Torres VE, Braun WE, Steinman TI, et al. Blood pressure in early autosomal dominant polycystic kidney disease. The New England journal of medicine. 2014;371(24):2255–66. 10.1056/NEJMoa1402685 .
    1. Colin-Ramirez E M F, Woo E, Wong N, Ezekowitz JA. Association between self-reported adherence to a low-sodium diet and dietary habits related to sodium intake in heart failure patients. J Cardiovasc Nurs 2015;30(1):58–65.
    1. Ogborn MR, Sareen S. Amelioration of polycystic kidney disease by modification of dietary protein intake in the rat. Journal of the American Society of Nephrology: JASN. 1995;6(6):1649–54. .
    1. Milas NC, Nowalk MP, Akpele L, Castaldo L, Coyne T, Doroshenko L, et al. Factors associated with adherence to the dietary protein intervention in the Modification of Diet in Renal Disease Study. J Am Diet Assoc. 1995;95(11):1295–300. .
    1. Mahajan A, Simoni J, Sheather SJ, Broglio KR, Rajab MH, Wesson DE. Daily oral sodium bicarbonate preserves glomerular filtration rate by slowing its decline in early hypertensive nephropathy. Kidney international. 2010;78(3):303–9. 10.1038/ki.2010.129 .
    1. Grantham JJ. Rationale for early treatment of polycystic kidney disease. Pediatric nephrology. 2014. 10.1007/s00467-014-2882-8 .
    1. Wang X, Wu Y, Ward CJ, Harris PC, Torres VE. Vasopressin directly regulates cyst growth in polycystic kidney disease. Journal of the American Society of Nephrology: JASN. 2008;19(1):102–8. 10.1681/ASN.2007060688
    1. Gattone VH 2nd, Wang X, Harris PC, Torres VE. Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist. Nature medicine. 2003;9(10):1323–6. 10.1038/nm935 .
    1. Brindal E, Hendrie G, Freyne J, Coombe M, Berkovsky S, Noakes M. Design and pilot results of a mobile phone weight-loss application for women starting a meal replacement programme. Journal of telemedicine and telecare. 2013. 10.1177/1357633X13479702 .

Source: PubMed

3
Se inscrever